Clinical Trials Directory

Trials / Unknown

UnknownNCT02544919

Lipids and Neurological Complications in Liver Transplantation

Impact of Pretreatment With Omega 3 Enriched Lipid Emulsion on Early Neurological Complications After Living Donor Liver Transplantation. A Randomized Controlled Trial>

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Mansoura University · Academic / Other
Sex
All
Age
20 Years – 60 Years
Healthy volunteers
Not accepted

Summary

To study the impact of pretreatment of living donor liver transplantation recipients with SMOF lipid on the incidence and severity of post-transplantation neurological complications in patients receiving tacrolimus based immunosuppression protocol

Detailed description

All patients included in the study will receive the same immuno-suppression protocol based on tacrolimus and mycophenolate mofetil after the induction immuno-suppression during the intra-operative period. Patients will have a full history taking and full neurological examination 48 hours prior to the designated operative date as a basal record. the control group will not receive any lipid infusions at all the treatment group will receive the study emulsion (SMOF lipid 20% - Fresenius Kabi) starting 48 hours before the planned surgery day and will continue to receive it for 5 post-operative days by intravenous infusion. During the post-operative period. patients will be assessed daily by full neurological examination as will as patient complaints (symptoms) related to neurological status for diagnosis of any neurological conditions (complications) that might arise during the study period. Data will be analysed compared to the basal value in each group and between both control and intervention groups using the appropriate statistical tests.

Conditions

Interventions

TypeNameDescription
DRUGSMOF lipid (SMOFLIPID) pre treatmentExperimental Arm

Timeline

Start date
2015-09-01
Primary completion
2017-09-01
Completion
2017-12-01
First posted
2015-09-09
Last updated
2017-03-27

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT02544919. Inclusion in this directory is not an endorsement.